Studies using mouse models suggest that dysbiosis could contribute to T2D and metabolic diseases through multiple mechanisms, including alteration of luminal SCFAs, especially butyrate11, the stool and serum BA pool6,17, and the incretin signaling39. This evidence concerns the gene GCG and Other metabolic disease.